Home › Prostate Cancer › Illinois › Carbondale
Prostate Cancer clinical trials in Carbondale, IL
3 studies for Prostate Cancer are looking for participants at sites in and around Carbondale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- Memorial Hospital of Carbondale, Carbondale
- SIH Cancer Institute, Carterville · 8 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Memorial Hospital of Carbondale, Carbondale
- SIH Cancer Institute, Carterville · 8 mi away
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecruitingPhase 3
- Memorial Hospital of Carbondale, Carbondale
- SIH Cancer Institute, Carterville · 8 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Carbondale
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer4 studies
- Colon Cancer4 studies
- Cancer (all types)3 studies
- Pancreatic Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Melanoma3 studies
- Triple-Negative Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.